WebJan 20, 2024 · IRVINE, CA, and HERSTAL, BELGIUM – January 20, 2024 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today provided supplemental information related to... WebFeb 13, 2024 · GPS predicts the likelihood of adverse pathology, prostate cancer death, and metastasis within 10 years. About mdxhealth® Mdxhealth is a commercial-stage …
MDxHealth Shareholder Transparency Declaration - Yahoo Finance
WebAug 2, 2024 · Michael McGarrity, CEO of mdxhealth, commented: "We are excited to announce this transformational acquisition of Oncotype DX GPS, a broadly commercialized and clinically validated test available today across the urology community, expanding mdxhealth's current menu of tests targeted into urology and prostate cancer and … WebMar 13, 2024 · IRVINE, CA, and HERSTAL, BELGIUM – March 13, 2024 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today confirms that neither MDxHealth SA, nor any of... free bring back love spell
MDxHealth Announces UnitedHealthcare to Provide Commercial …
WebMar 8, 2024 · mdxhealth [email protected] LifeSci Advisors (IR & PR) US: +1 949 271 9223 [email protected] NOTE: The mdxhealth logo, mdxhealth, Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate... WebMar 8, 2024 · 2024 full year revenues increased by 67% to $37.1 million versus $22.2 million for 2024; excluding GPS, 2024 revenue increased 25% to $27.7 million versus 2024. … WebApr 7, 2024 · mdxhealth [email protected] LifeSci Advisors (IR & PR) US: +1 949 271 9223 [email protected] NOTE: The mdxhealth logo, mdxhealth, Confirm mdx, Select … blocked weight